MiR-149-3p Targeting TMPRSS4 Regulates the Sensitivity to Cisplatin to Inhibit the Progression of Lung Cancer. Biomol Biomed 2024, 25 (1), 165–176. https://doi.org/10.17305/bb.2024.11163.